What amount sold does Transdermal Sedation Solutions, LLC report in Form D filings?

The latest linked filings report $50K sold across 1 identified offering(s). 0 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was Transdermal Sedation Solutions, LLC's most recent SEC filing?

Transdermal Sedation Solutions, LLC's most recent Form D filing was on 2019-12-12.

How many investors does Transdermal Sedation Solutions, LLC have?

The most recent Form D filing lists 5 investor(s).

What type of securities does Transdermal Sedation Solutions, LLC offer?

Transdermal Sedation Solutions, LLC's SEC Form D filings indicate equity offerings.

Transdermal Sedation Solutions, LLC

CIK: 0001796637·Pharmaceuticals·LITTLE ROCK, AR·Limited Liability Company·Founded 2019

Reported Sold

$50,000

Total Filings

Identified Offerings

Last Filed

Dec 12, 2019

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately.

About

Company in Pharmaceuticals industry

SEC EDGAR

Offering filing timeline

Dec 12, 2019Form D — New notice

Reported sold: $50,000 · Target: $50,000

Rule 506(b)·5 investors·Section 4(a)(5)

Fundraising Profile

Exemptions

Rule 506(b)

Investors in latest filing

Revenue Range

No Revenues

Reported commissions across identified offerings

Amendment Rate

Latest reported sold across 1 identified offering

$50,000

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

Key People

James L McCarley, Jr.

Related Person

Appears on 1 filing

Willie Charles Mitchell

Related Person

Appears on 1 filing

Denise Lynn Rivkees

Related Person

Appears on 1 filing

Pamala Lea Wilson

Related Person

Appears on 1 filing

Janna McIntosh

Related Person

Appears on 1 filing

Filing History

Date	Type	Offering target	Reported sold	Investors
Dec 12, 2019	New	$50,000	$50,000	5

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

Spiritus, Inc.

Pharmaceuticals

Offering target: $68,470

Filed Oct 13, 2026